Prognostic significance of pathologically proven chronic fibrosing interstitial lung diseases with a progressive phenotype (PF-ILDs): single center retrospective cohort
Y. Nakamura (nagasone city, Japan), T. Takimoto (nagasone city, Japan), T. Arai (nagasone city, Japan), N. Takeuchi (nagasone city, Japan), R. Sugawara (nagasone city, Japan), K. Katayama (nagasone city, Japan), S. Minomo (nagasone city, Japan), C. Sugimoto (nagasone city, Japan), K. Tachibana (nagasone city, Japan), M. Akira (nagasone city, Japan), T. Kasai (nagasone city, Japan), S. Hayashi (nagasone city, Japan), Y. Inoue (nagasone city, Japan)
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Nakamura (nagasone city, Japan), T. Takimoto (nagasone city, Japan), T. Arai (nagasone city, Japan), N. Takeuchi (nagasone city, Japan), R. Sugawara (nagasone city, Japan), K. Katayama (nagasone city, Japan), S. Minomo (nagasone city, Japan), C. Sugimoto (nagasone city, Japan), K. Tachibana (nagasone city, Japan), M. Akira (nagasone city, Japan), T. Kasai (nagasone city, Japan), S. Hayashi (nagasone city, Japan), Y. Inoue (nagasone city, Japan). Prognostic significance of pathologically proven chronic fibrosing interstitial lung diseases with a progressive phenotype (PF-ILDs): single center retrospective cohort. 3537
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: